The global Nucleic Acid Testing Market was valued at USD 4.23 Billion in 2022. It is projected to reach USD 7.57 Billion by 2032, with a compound annual growth rate (CAGR) of 6.7% during the forecast period. The market is primarily propelled by the increasing occurrence of infectious diseases and the need for accurate and rapid diagnostic tests. Nucleic Acid Testing (NAT), a technology...